|
|
|
11-50 employees
View all
|
|
Pharmaceuticals
|
|
Suite 216,Blacksburg,VA,US
|
|
Landos Biopharma, Inc. | 1,028 followers on LinkedIn. Accelerated Path to Cures | Landos Biopharma, Inc (NASDAQ: LABP) is a late-clinical-stage biopharmaceutical company utilizing its LANCE Advanced A.I. platform to discover and develop novel oral therapeutics for patients with autoimmune diseases. LANCE has discovered new mechanisms of action, including the LANCL2, NLRX1 and PLXDC2 immunometabolic pathways. Landos has 17 active development programs targeting these novel pathways at the interface of immunity and metabolism.
|
Landos Biopharma, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Landos Biopharma, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Landos Biopharma, Inc. customer service number in your country click here to find.
Gregory Oakes is the CEO of Landos Biopharma, Inc.. To contact Gregory Oakes email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.